PORTLAND, Oregon (PRWEB) April 28, 2006
Dr. Bruce Gibbins, the founder and chief technology officer of Portland-based AcryMed Inc., earlier this month was awarded the Distinguished Alumni Award from Washington State University’s College of Science. The honor is given each year to a single alumni member for his or her outstanding achievements in the field of science. Gibbins’ work in infection control and wound healing technology has resulted in a number of life-saving medical breakthroughs including recent discoveries in nanotechnology that have resulted in a new medical device treatment process that can halt the spread of deadly infections.
Gibbins received a Bachelors of Science degree from Washington State University in 1970. He also earned a Masters of Science degree in 1973 and a PhD in 1975, both from Washington State University.
“Dr. Gibbins is a pioneer in the field of silver antimicrobial infection control technology,” said Michael Griswold, Dean of Sciences at Washington State University. “His groundbreaking work in the laboratory as well as his dedication in the field are exemplary and it is our honor to present him with this award.”
After obtaining his Ph.D. in Bacteriology and Public Health from Washington State University, Gibbins spent several years as a faculty member of the Department of Microbiology at the University of Otago Medical School in New Zealand. While there he also helped start a company that developed the prototype for a new skin substitute material. Gibbins eventually purchased the patents to this technology and moved back to the U.S. where in 1993, he founded AcryMed Inc., a company dedicated to the advancement of wound care and infection control technology.
At AcryMed, Gibbins perfected the work he began in New Zealand which eventually led to the creation and market introduction of Microlattice®, an advanced tissue repair product that controls moisture in the wound site to ensure maximum healing.
Gibbins also focused his attention on the antimicrobial properties of silver. He and AcryMed researcher Lance Hopman perfected the stabilization of silver in a moist environment, leading to the development of the world’s first moisture containing silver antimicrobial wound dressing.
In 2001 Gibbins and his team of scientists at AcryMed developed the first silver antimicrobial gel. Solving many of the problems associated with the medical application of antimicrobial silver, SilvaSorb® gel offers an easy way to apply a highly effective broad spectrum bacteria fighting agent to virtually any type of wound or burn.
Gibbins led a team that included Dr. Bhalachandra Karandikar in developing a silver antimicrobial application process to tackle the devastating effects caused by hospital-acquired infections. In 2005, Gibbins and his team of scientist discovered a way to apply silver nanoparticles to the surface of medical devices. Unlike any other medical device treatment process available today, SilvaGard™ nanotechnology allows medical device manufacturer to easily and cost effectively render their medical devices resistant to infection-causing bacteria.
Due to his expertise in wound healing technology, Gibbins was asked to share his knowledge with medical professionals in China where chronic wounds caused by diabetic ulcers are epidemic. Starting in 2004, Gibbins has led a team of doctors and nurses on several trips to China where they examine patients and provide training to medical staff. Dr. Gibbins is currently playing a leading role in establishing a center of excellence for wound care in Guangzhou, China. The new institute will serve as a training center and hospital dedicated to the treatment of chronic wounds.
“We are at the forefront of a medical revolution in the area of advancing wound care and in controlling hospital acquired infections,” said Gibbins. “I am continually grateful for the broad platform of education and training I received from WSU that has helped to prepare me for contributing to the development of products and technologies for wound care and infection control.”
For more information on Dr. Gibbins and the work he is leading at AcryMed Inc., visit http://www.acrymed.com or call Brad Brenner at 503-736-0610.